Cytek Biosciences, Inc. (NASDAQ:CTKB)
| Market Cap | $800.40M+4.1% |
| Revenue (ttm) | $207.65M+5.5% |
| Net Income | -$81.20M-533.4% |
| EPS | -$0.63-504.0% |
| Shares Out | 130.78M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,765,925 |
| Open | $6.22 |
| Previous Close | $6.32 |
| Day's Range | $5.99 - $6.39 |
| 52-Week Range | $3.31 - $6.39 |
| Beta | 1.14 |
| Analysts | Buy |
| Price Target | $5.50(-10.13%) |
| Earnings Date | Feb 25, 2027 |
About CTKB
Cytek Biosciences, Inc. is a company dedicated to cell analysis solutions, offering advanced tools that facilitate scientific progress in both biomedical research and clinical settings. Their primary offerings include the Aurora and Northern Lights spectrum flow cytometers. These instruments conduct comprehensive cell analysis by leveraging fluorescence signatures from multiple lasers to differentiate between various fluorescent tags on individual cells. Complementing these, the Aurora Cell Sorter system utilizes full spectrum profiling technology to broaden the range of potential applications in cell analysis. Beyond instrumentation, Cytek provides essential reagents and kits. These include cFluor reagents, which are antibodies conjugated with fluorochromes, specifically designed to identify target cells for analysis on their systems. They also offer a 25-color immunoprofiling assay, a ready-to-use solution for pinpointing major human immune cell subpopulations like TBNK cells, monocytes, dendritic cells, and basophils. To streamline laboratory operations, the company offers automated micro-sampling and sample loader systems. These automated plate loaders are engineered to integrate seamlessly with the Aurora and Northern Lights systems. The intuitive SpectroFlo software accompanies these systems, simplifying the workflow from quality control through to data analysis. Cytek also provides comprehensive customer support resources. Cytek's diverse client base includes pharmaceutical and biopharmaceutical companies, academic research institutions, and clinical research organizations. The company distributes its products through a direct sales force and dedicated support teams in North America, Europe, China, and the Asia-Pacific region. Additionally, it partners with distributors and sales agents to serve markets across European, Latin American, Middle Eastern, and other Asia-Pacific countries. Originally established in 1992 as Cytoville, Inc., the company officially adopted the name Cytek Biosciences, Inc. in August 2015. Its corporate headquarters are situated in Fremont, California.
Analyst consensus
1 firm rating CTKB in the last 3 months, one vote each. Issuer-paid research is not counted.
Next catalysts
- Feb 25, 2027Earnings report
$CTKB stock is featured in our Insider Trades datasets.
→ All Stock ListsRecently reported changes in CTKB holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by CTKB's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
CTKB Estimated quarterly lobbying spending
Source: U.S. Senate LDA
CTKB Revenue by Segment or Geography
| Direct sales channel | $42.30M | 54.42% |
| Academia and government | $24.51M | 31.53% |
| Distributor channel | $10.93M | 14.05% |
As of: Q3 2026 (Sep 30, 2026) · Source: SEC EDGAR (10-Q)
U.S. Patents
New CTKB patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to CTKB from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in CTKB
| IWMiShares Russell 2000 ETF | $20.17M |
| VTIVanguard Morningstar Total Stock Market ETF | $17.03M |
| VXFVanguard Extended Market ETF | $7.73M |
| IWNiShares Russell 2000 Value ETF | $7.21M |
| IBBiShares Biotechnology ETF | $5.84M |
| DFASDimensional - US Small Cap ETF | $5.27M |
Estimated from each fund’s disclosed top holdings × AUM
Bull Case vs Bear Case
AI-generated from CTKB’s recent data — informational, not investment advice
What’s Behind the Score
Recent Insider Activity
Frequently Asked Questions
ETFs that hold this stock
| VFLQ | Vanguard U.S. Liquidity Factor ETF | 0.43% |
| FSEV | Fidelity Enhanced Small Cap Value ETF | 0.31% |
| EKG | First Trust Nasdaq Lux Digital Health Solutions ETF | 0.25% |
| RUSC | Russell Investments Exchange Traded Funds - Russell Investments US Small Cap Equity ETF | 0.19% |
| GSSC | Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF | 0.09% |
| SLY | SPDR S&P 600 Small Cap ETF | 0.08% |
| FESM | Fidelity Enhanced Small Cap ETF | 0.07% |
| VTWV | Vanguard Russell 2000 Value ETF | 0.05% |
| IWN | iShares Russell 2000 Value ETF | 0.05% |
| IBB | iShares Biotechnology ETF | 0.05% |
| VHT | Vanguard Health Care ETF | 0.01% |
Weight is the stock’s share of each fund’s holdings.
